Cathepsin K: boon or bale for atherosclerotic plaque stability?

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cathepsin K: boon or bale for atherosclerotic plaque stability?

Cathepsins, cysteine proteases of lysosomes and endosomes, play major physiological roles in general intracellular protein turnover. When they are directed outside the cell, these enzymes also take part in remodelling the extracellular matrix of bone and other tissues. Once in the extracellular matrix, the cathepsins degrade elastin and collagen. Since remodelling of the extracellular matrix of...

متن کامل

Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability

Investigating the determinants and dynamics of atherosclerotic plaque instability is a key area of current cardiovascular research. Extracellular matrix degradation from excessive proteolysis induced by enzymes such as cathepsin K (Cat K) is implicated in the pathogenesis of unstable plaques. The current study assessed the expression of Cat K in human unstable atherosclerotic plaques. Specimens...

متن کامل

Atherosclerotic plaque rupture: local or systemic process?

It is generally established that the unstable plaque is the major cause of acute clinical sequelae of atherosclerosis. Unfortunately, terms indicating lesions prone to plaque instability, such as "vulnerable plaque," and the different phenotypes of unstable plaques, such as plaque rupture, plaque fissuring, intraplaque hemorrhage, and erosion, are often used interchangeably. Moreover, the diffe...

متن کامل

Fibronectin extradomain A: balancing atherosclerotic plaque burden and stability.

Fibronectin is a crucial extracellular matrix (ECM) protein regulating ECM-dependent cell adhesion, migration, and differentiation. Besides being deposited as insoluble fibrils in tissues, it is also produced as soluble dimers by the liver and released in plasma. The presence of fibronectin in atherosclerotic plaques was described more than 20 years ago and plasma fibronectin has been shown to ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Cardiovascular Research

سال: 2008

ISSN: 0008-6363

DOI: 10.1093/cvr/cvn343